Search results for "lesion"

showing 10 items of 1094 documents

Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry

2016

Objectives The aim of this study was to evaluate midterm outcomes of bioresorbable vascular scaffolds (BVS) implanted in bifurcation lesions. Background BVS have emerged as an alternative to conventional metallic drug-eluting stents for the treatment of coronary complex lesions. Methods Between November 2011 and January 2014, 1189 patients underwent percutaneous coronary intervention with BVS at 10 European centers (GHOST EU registry). Of these, 289 consecutive patients (302 bifurcation lesions) treated with either single-stenting (n = 260) or double-stenting (n = 42) were evaluated. Results True bifurcations were treated in 44.7%. Intravascular ultrasound and optical coherence tomography w…

Target lesionmedicine.medical_specialtyAcute coronary syndromeeducation.field_of_studymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentPopulationPercutaneous coronary interventionGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseBalloonSurgeryCoronary artery disease03 medical and health sciences0302 clinical medicineCoronary thrombosisIntravascular ultrasoundMedicineRadiology Nuclear Medicine and imaging030212 general & internal medicineCardiology and Cardiovascular MedicinebusinesseducationCatheterization and Cardiovascular Interventions
researchProduct

Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB regis…

2021

Abstract Objectives To identify potential differences in 2‐year outcome between patients who underwent coronary revascularization using bioresorbable vascular scafffolds (BVS) in stable coronary artery disease (CAD) and acute coronary syndromes (ACS). Background Data from randomized trials suggest a significantly higher event rate following coronary revascularization using everolimus‐eluting BVS as compared to new generation drug eluting stents. Whether particular patient subgroups are at increased risk for scaffold thrombosis and target lesion failure (TLF) has not clearly been demonstrated. Methods German‐Austrian ABSORB RegIstRy is a prospective all‐comer multi‐center observational study…

Target lesionmedicine.medical_specialtyTime FactorsMedizinCoronary Artery Disease030204 cardiovascular system & hematologyProsthesis Designlaw.inventionCoronary artery disease03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineRandomized controlled triallawInternal medicineAbsorbable ImplantsmedicineHumansRadiology Nuclear Medicine and imagingIn patientEverolimusProspective StudiesRegistries030212 general & internal medicineddc:610Acute Coronary SyndromeEverolimusbusiness.industryGeneral Medicinemedicine.diseaseThrombosisStenosisTreatment OutcomeAustriaCardiologyCardiology and Cardiovascular MedicinebusinessMacemedicine.drug
researchProduct

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions

2017

Abstract Objectives The authors sought to investigate 1-year outcomes in patients treated with bioresorbable everolimus-eluting vascular scaffolds (BVS) for “long coronary lesions.” Background The present substudy derived from the GHOST-EU registry included 1,722 lesions in 1,468 consecutive patients, enrolled between November 2011 and September 2014 at 11 European centers. Methods The lesions were divided into 3 groups according to continuous BVS length: 1) shorter than 30 mm; 2) between 30 and 60 mm; and 3) longer than 60 mm. Primary device-oriented endpoint (target lesion failure [TLF]) was defined as a combination of cardiovascular death, target vessel myocardial infarction, or clinical…

Target lesionmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentPercutaneous coronary intervention030204 cardiovascular system & hematologymedicine.diseaseSurgeryCoronary artery diseaseLesion03 medical and health sciences0302 clinical medicineCoronary thrombosisInterquartile rangeCardiovascular agentMedicine030212 general & internal medicineMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessJACC: Cardiovascular Interventions
researchProduct

Long-term outcome after drug-eluting stents implantation: Target lesion versus nontarget lesion repeated intervention

2010

Abstract We sought to investigate the relative clinical significance of target and nontarget lesions repeated percutaneous coronary intervention (re-PCI) in patients implanted with drug-eluting stents (DES). Out of 2626 consecutive DES patients, we retrospectively selected 166 (6.3%; 123 males, aged 65±10years) who had a clinically-driven re-PCI over a mean follow-up of 15months. Seventy-five patients (45%) underwent the second procedure for disease progression in nontarget lesions (nontarget lesion re-PCI group) while 91 (55%) showed target lesion in-stent restenosis or thrombosis (target lesion re-PCI group), with no significant intergroup difference in the temporal trends of re-PCI. The …

Target lesionmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionmedicine.diseaseSurgeryCoronary artery diseaseLesionAtherectomysurgical procedures operativeRestenosisDrug-eluting stentAngioplastymedicinecardiovascular diseasesRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinesstherapeuticsInternational Journal of Cardiology
researchProduct

Real-Life Outcomes of Coronary Bifurcation Stenting in Acute Myocardial Infarction (Zabrze–Opole Registry)

2021

Percutaneous coronary intervention (PCI) of bifurcation lesions is a technical challenge associated with high risk of adverse events, especially in primary PCI. The aim of the study is to analyze long-term outcomes after PCI for coronary bifurcation in acute myocardial infarction (AMI). The outcome was defined as the rate of major adverse cardiac event related to target lesion failure (MACE-TLF) (death-TLF, nonfatal myocardial infarction-TLF and target lesion revascularization (TLR)) and the rate of stent thrombosis (ST). From 306 patients enrolled to the registry, 113 were diagnosed with AMI. In the long term, AMI was not a risk factor for MACE-TLF. The risk of MACE-TLF was dependent on th…

Target lesionmedicine.medical_specialtymedicine.medical_treatmentacute myocardial infarctionCulpritArticlemedicine.arteryInternal medicinemedicineDiseases of the circulatory (Cardiovascular) systemPharmacology (medical)cardiovascular diseasesMyocardial infarctionGeneral Pharmacology Toxicology and PharmaceuticsRisk factoracute myocardial infarction; coronary bifurcation; percutaneous coronary intervention; target lesion failureAdverse effectcoronary bifurcationbusiness.industrypercutaneous coronary interventionPercutaneous coronary interventionmedicine.diseaseRC666-701Right coronary arteryConventional PCICardiologytarget lesion failurebusinessJournal of Cardiovascular Development and Disease
researchProduct

Modeling Vestibular Compensation: Neural Plasticity Upon Thalamic Lesion.

2020

The present study in rats was conducted to identify brain regions affected by the interruption of vestibular transmission and to explore selected aspects of their functional connections. We analyzed, by positron emission tomography (PET), the regional cerebral glucose metabolism (rCGM) of cortical, and subcortical cerebral regions processing vestibular signals after an experimental lesion of the left laterodorsal thalamic nucleus, a relay station for vestibular input en route to the cortical circuitry. PET scans upon galvanic vestibular stimulation (GVS) were conducted in each animal prior to lesion and at post-lesion days (PLD) 1, 3, 7, and 20, and voxel-wise statistical analysis of rCGM a…

Thalamusneuronal tracingSensory systemSomatosensory systemInsular cortexlcsh:RC346-429Lesionlesion03 medical and health sciences0302 clinical medicinethalamusMedicinePET-imagingimmunofluorescenceGalvanic vestibular stimulationlcsh:Neurology. Diseases of the nervous system030304 developmental biologyOriginal ResearchVestibular system0303 health sciencesbusiness.industrymedicine.anatomical_structureNeurologyCerebral cortexcerebral cortexNeurology (clinical)medicine.symptombusinessNeuroscience030217 neurology & neurosurgeryFrontiers in neurology
researchProduct

Tumor hypoxia and therapeutic resistance

2008

For many years, the identification of tumor hypoxia, its systematic characterization and the assessment of its clinical relevance were not possible due to the lack of methods suitable for the routine measurement of intratumoral oxygen tensions in patients. In the late 1980s, a novel and clinically applicable standardized procedure was established enabling the determination of tumor oxygenation in accessible primary tumors, local recurrences, and metastatic lesions in patients using a computerized polarographic needle electrode system (Vaupel et al. 1991; Hockel et al. 1991). Within a relatively short period of time, the significance of tumor oxygenation for therapy outcome became evident in…

Therapy OutcomeOncologyNeedle electrodemedicine.medical_specialtyMetastatic lesionsTumor hypoxiabusiness.industryTherapeutic resistanceTumor OxygenationInternal medicineMedicineClinical significanceIn patientbusiness
researchProduct

Tumor Oxygenation and Its Relevance to Tumor Physiology and Treatment

2003

For many years, the identification of tumor hypoxia, its systematic characterization and the assessment of its clinical relevance were not possible due to lack of methods suitable for the routine measurement of intratumoral oxygen tensions in patients. In the late 1980s, a novel and clinically applicable standardized procedure was established enabling the determination of the tissue oxygenation status in primary tumors, local recurrences, and metastatic lesions in patients using a computerized polarographic needle electrode system. Within a relatively short period of time, the significance of tumor oxygenation for therapy outcome became evident in numerous experimental and clinical studies.

Therapy Outcomemedicine.medical_specialtyNeedle electrodeTissue oxygenationMetastatic lesionsTumor hypoxiabusiness.industrymedicineIn patientClinical significanceRadiologyTumor Oxygenationbusiness
researchProduct

Thyroid sarcoidosis as a unique localization.

2006

Sarcoidosis is a systemic disorder characterized by granulomatous lesions, principally affecting the lungs. There are numerous reports in the literature of an associated involvement of the thyroid, much more frequently in hypothyroid than in hyperthyroid subjects. The present case report refers to a woman presenting with thyroid nodules and normal biochemical levels and thyroid function parameters, while histology revealed sarcoid-type lesions. Subsequent investigations and a long follow-up showed no evidence of involvement of other sites, including the lungs. Consequently, after a long period of normal health associated with the negative results of the examinations, a diagnosis of sarcoido…

Thyroid nodulesAdultendocrine systemPathologymedicine.medical_specialtyendocrine system diseasesSarcoidosisEndocrinology Diabetes and Metabolismmedicine.medical_treatmentgranulomasThyroid GlandSarcoidosiSettore MED/08 - Anatomia PatologicaEndocrinologyLong periodmedicineHumansGranulomatous lesionsThyroidGranulomabusiness.industryThyroidThyroidectomyHistologymedicine.diseasemedicine.anatomical_structureThyroidectomyFemaleSarcoidosisThyroid functionbusinessGoiter Nodular
researchProduct

Liver Preservation by Aortic Perfusion Alone Compared With Preservation by Aortic Perfusion and Additional Arterial Ex Situ Back-Table Perfusion With…

2017

Background. Arterial ex situ back-table perfusion (BP) reportedly reduces ischemic-type biliary lesion after liver transplantation. We aimed to verify these findings in a prospective investigation. Methods. Our prospective, randomized, controlled, multicenter study involved livers retrieved from patients in 2 German regions, and compared the outcomes of standard aortic perfusion to those of aortic perfusion combined with arterial ex situ BP. The primary endpoint was the incidence of ischemic-type biliary lesions over a follow-up of 2 years after liver transplantation, whereas secondary endpoints included 2-year graft survival, initial graft damage as reflected by transaminase levels, and fu…

Transplantationmedicine.medical_specialtyHistidine-tryptophan-ketoglutarate solutionbusiness.industrymedicine.medical_treatmentlcsh:SurgeryMedizinlcsh:RD1-811030230 surgeryLiver transplantation019Liver TransplantationLesion03 medical and health sciences0302 clinical medicineMulticenter studyInternal medicinemedicineCardiology030211 gastroenterology & hepatologymedicine.symptombusinessLiver preservationPerfusion
researchProduct